How the paediatric workforce can address the opioid crisis

The Lancet

Volumn 388, Issue 10051, 2016, Pages 1260-1261

  Hadland, Scott E ^a,b,c   Wood, Evan ^d,e   Levy, Sharon ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ST PAUL S HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

DEPRESSION; DRUG USE; HEALTH CARE MANPOWER; HEALTH CARE POLICY; HUMAN; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NOTE; PEDIATRICIAN; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; ADOLESCENT; DRUG OVERDOSE; EUROPE; FEMALE; INCIDENCE; MALE; MANPOWER; OPIATE SUBSTITUTION TREATMENT; PEDIATRICS; PRIMARY HEALTH CARE; PROCEDURES; STANDARDS; SUBSTANCE-RELATED DISORDERS; TRENDS; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ANALGESICS, OPIOID; DRUG OVERDOSE; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; OPIATE SUBSTITUTION TREATMENT; PEDIATRICS; PRIMARY HEALTH CARE; SUBSTANCE-RELATED DISORDERS; UNITED KINGDOM; UNITED STATES;

EID: 84991383513     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31573-2     Document Type: Note

References (12)

1. 1 United Nations Office on Drugs and Crime. World drug report 2016, 2016, United Nations, New York, NY.
2. 2 Vos, T, Barber, RM, Bell, B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2016), 743–800.
3. 3 Rudd, RA, Aleshire, N, Zibbell, JE, Gladden, RM, Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep 64 (2016), 1378–1382.
4. 4 Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2003–2013. National admissions to substance abuse treatment services, 2015, Substance Abuse and Mental Health Services Administration, Rockville, MD.
5. 5 American Academy of Pediatrics Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics, 138, 2016, e20161893.
6. 6 Ford, C, Halliday, K, Lawson, E, Browne, E, Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care, 2011, Royal College of General Practitioners, London, UK.
7. 7 Dunlap, B, Cifu, AS, Clinical management of opioid use disorder. JAMA 316 (2016), 338–339.
8. 8 Han, B, Hedden, SL, Lipari, R, Copello, EA, Kroutil, LA, Receipt of services for behavioral health problems: results from the 2014 National Survey on Drug Use and Health, 2015, Substance Abuse and Mental Health Services Administration, Rockville, MD.
9. 9 Knudsen, HK, Abraham, AJ, Roman, PM, Adoption and implementation of medications in addiction treatment programs. J Addict Med 5 (2011), 21–27.
10. 10 Bateman, J, Gilvarry, E, Tziggili, M, Crome, IB, Mirza, K, McArdle, P, Psychopharmacological treatment of young people with substance dependence: a survey of prescribing practices in England. Child Adolesc Ment Health 19 (2014), 102–109.
11. 11 Richardson, LP, Ludman, E, McCauley, E, et al. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA 312 (2014), 809–816.
12. 12 Komaromy, M, Duhigg, D, Metcalf, A, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus 37 (2016), 20–24.